Pyrido(2,3-d)pyrimidin-4(3h)-ones
    71.
    发明授权
    Pyrido(2,3-d)pyrimidin-4(3h)-ones 失效
    吡啶(2,3-D)嘧啶-4(3H) - 酮

    公开(公告)号:US3794637A

    公开(公告)日:1974-02-26

    申请号:US3794637D

    申请日:1971-07-22

    IPC分类号: C07D471/04 C07D51/46

    CPC分类号: C07D471/04 Y10S514/869

    摘要: PYRIDO-(2,3-D)PYRIMIDIN-4(3H)-ONES OF THE GENERAL FORMULA 2-(R1-N(-R2)-),4-(O=)-3,4-DIHYDROPYRIDO(2,3-D)PYRIMIDINE WHEREIN R1 IS A LOWER ALKYL, ALKENUL, CYCLOALKYL, ARALKYL, FURYLALKYL, THIENYLALKYL OR TETRAHYDROFURYLALKYL RADICAL, OPTIONALLY SUBSTITUTED BY HYDROXY. ALKOXY OR ALKYLMERCAPTO RADICALS AND R2 IS R1 OR HYDROGEN, AND THE SALTS THEREOF WITH PHYSIOLOGICALLY COMPATIBLE ACIDS. THESE COMPOUNDS EXHIBIT LONGLASTING DIURETIC ACTION.

    Dragee sorting apparatus
    72.
    发明授权
    Dragee sorting apparatus 失效
    DRAGOR SORTING APPARATUS

    公开(公告)号:US3784006A

    公开(公告)日:1974-01-08

    申请号:US3784006D

    申请日:1972-06-28

    发明人: BRAUN H

    IPC分类号: B07C5/06 B07C

    摘要: Apparatus for sorting dragees according to diameter and thickness of the dragees, which apparatus comprises, in combination, (a) plate-type sorting means comprising a perforated surface adjustable in tilt and oscillatable and disposed to receive the dragees to be sorted and, disposed therebelow, (b) roller-type sorting means comprising a plurality of substantially parallel rollers wherein adjacent rollers rotate in opposite directions and wherein the spacing between said rollers is steplessly adjustable.

    摘要翻译: 用于根据糖衣丸的直径和厚度分配糖衣丸的装置,该装置组合包括(a)板式分选装置,其包括可倾斜地调节并可摆放的穿孔表面,并设置成容纳待分类的糖衣并布置在其下方 ,(b)滚子式分选装置,其包括多个基本平行的辊,其中相邻的辊沿相反方向旋转,并且其中所述辊之间的间隔是无级可调的。

    N(6)-benzyl-adenosine compounds and therapeutic compositions
    73.
    发明授权
    N(6)-benzyl-adenosine compounds and therapeutic compositions 失效
    N(6) - 苯亚胺化合物和治疗组合物

    公开(公告)号:US3781273A

    公开(公告)日:1973-12-25

    申请号:US3781273D

    申请日:1971-02-03

    CPC分类号: C07H19/16

    摘要: NOVEL 2,3- OR 2-5 DISUBSTITUTED N (6)-BENZYL-ADENOSINE DERIVATIVES OF THE FOLLOWING FORMULA

    9-(3,4,5-TRI(HO-)TETRAHYDROFUR-2-YL),6-((2-R1,3-R2,5-R3-

    PHENYL)-CH2-NH-)-9H-PURINE

    WHEREIN

    R1 IS HALOGEN, ALKYL, ALKOXY OR ALKYLTHIO; R2 AND R3 ARE MEMBERS OF THE GROUP CONSISTING OF HYDROGEN, HALOGEN, ALKYL, ALKOXY AND ALKYLTHIO WITH THE PROVISO THAT ONE AND ONLY ONE OF R2 AND R3 IS HYDROGEN; ARE OUTSTANDING EFFECTIVE CORONARY DILATORS AND LOWER THE FREE FATTY ACID CONTENT OF SERUM.

    Process for the preparation of creatine phosphate
    79.
    发明授权
    Process for the preparation of creatine phosphate 失效
    制备酸性磷酸盐的方法

    公开(公告)号:US3639211A

    公开(公告)日:1972-02-01

    申请号:US3639211D

    申请日:1968-11-19

    发明人: BEAUCAMP KLAUS

    IPC分类号: A23J3/00 C07F9/22 C12D13/06

    CPC分类号: C07F9/222 A23J3/04

    摘要: Process for preparing creatine phosphate comprising incubating in an alkaline medium creatine and 3-phosphoglyceric acid with an aqueous muscle extract in the presence of a catalytic amount of adenosine triphosphate, heating the resulting mixture for a short period of time to a temperature of 70* to 100* C. and recovering the creatine phosphate which is thereby formed.

    摘要翻译: 制备肌酸磷酸盐的方法包括在催化量的三磷酸腺苷存在下,用肌肉提取液在碱性介质肌酸和3-磷酸甘油酸中孵育,将所得混合物短时间内加热至70℃至 并回收由此形成的磷酸肌酸。

    Diagnostic agent for use in the determination of hydroperoxides and of peroxidate-active substances
    80.
    发明授权
    Diagnostic agent for use in the determination of hydroperoxides and of peroxidate-active substances 失效
    诊断用于确定水合氧化物和过氧化物活性物质的诊断试剂

    公开(公告)号:US3630847A

    公开(公告)日:1971-12-28

    申请号:US3630847D

    申请日:1968-07-17

    摘要: IN WHICH R1 is hydroxyl, unsubstituted or substituted amino, wherein the substituent is an aliphatic, araliphatic, cycloaliphatic, heterocyclic or aromatic radical, which in turn is substituted by one or more of hydroxy, amino and alkoxy; R3, R2 and R5 are each one of hydrogen, amino, hydroxy or alkoxy and R4 is hydrogen or the substituent R1. The diagnostic agents can be used for analytical determinations involving, for example, glucose, galactose, amino acids, uric acid, peroxide, hemoglobin, peroxidase, etc. in samples, for example, constituting biological fluids such as blood, urine, spinal fluid, etc., milk, cosmetic and drug formulations, etc.

    Diagnostic agents suitable for use in carrying out rapid analytical determinations of the presence and/or concentration of hydroperoxide substances which react with the liberation of hydrogen peroxide, peroxidase and peroxidate active substances comprising an indicator, i.e., chromogen, which is oxidized by hydrogen peroxide, peroxidase or peroxidate active substances to form a dyestuff, the color intensity of which is dependent on the peroxide, peroxidase or peroxidate active substance present in the test sample, wherein the chromogen is a compound having the formula: